Clinical Trial Update: Interest of TEG6S® in Reducing Transfusion Needs During Postpartum Haemorrhage

View source ↗

Summary

A completed clinical trial evaluating the use of the TEG6S viscoelastic testing system to reduce transfusion needs in postpartum hemorrhage.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Postpartum Hemorrhage

Snippet

Sponsor: Centre Hospitalier Sud Francilien | Conditions: Postpartum Hemorrhage | Status: COMPLETED